Health

Q&A with Jay Crone and Jon Wolkin, directors, Telus Ventures

Baidu’s corporate venturing arm has re-invested in the immunotherapy developer to help commercialise its pipeline.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Senior care provider Homage has added series C financing to its coffers.

The data analytics software producer, which counts Alphabet, Salesforce and Amazon among as backers, raised a $1.6bn series H at $38bn valuation. It is a case in point for the upward pressure in valuations of companies from this space which we have been seeing.

Versanis Bio secured $70 to commercialise a treatment licensed from Novartis, while Salesforce, Intel, Orange, Nike and Alphabet all celebrated exits.

Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

Alexandria Venture Investments is among the investors supporting the immunotherapy developer focused on cancer, autoimmune and infectious diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Penn Medicine and Wharton Social Impact Initiative have launched an investment fund focused on the drivers of health equity.